ArticleInternational journal of general medicine2026
Integrative Transcriptomic Analysis and Preliminary Peripheral Blood Evaluation Identify
Article in International journal of general medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Complete androgen insensitivity syndrome (CAIS) is a rare 46,XY disorder/difference of sex development (DSD) caused by impaired androgen receptor (AR) function. Although Methods: Two CAIS-related RNA-seq datasets from the Gene Expression Omnibus (GEO) were analyzed separately rather than merged at the expression-matrix level. GSE125222 included testicular tissue from 3 CAIS cases and 3 normal-spermatogenesis controls on GPL20301/Illumina HiSeq 4000. GSE300211 included 64 genital skin fibroblast libraries from 12 control and 4 CAIS fibroblast lines treated with ethanol or 10 nM dihydrotestosterone for 48 or 72 h on GPL30173/NextSeq 2000. Differential expression analysis, weighted gene co-expression network analysis (WGCNA), least absolute shrinkage and selection operator (LASSO), random forest, and support vector machine-recursive feature elimination (SVM-RFE) were used to prioritize exploratory candidate genes. Results: Conclusion:
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.